Condition Lookup
Sub-Category:
Pathologic Toxins
Number of Conditions: 2
Sepsis-related toxins (cytokine storm)
Specialty: Toxicology
Category: Endogenous Toxins
Sub-category: Pathologic Toxins
Symptoms:
fever; chills; rapid heart rate; shortness of breath; confusion; low blood pressure; organ dysfunction; rash or mottled skin; low blood pressure; organ dysfunction
Root Cause:
An excessive immune response to infection leads to widespread release of pro-inflammatory cytokines, causing systemic inflammation and organ damage.
How it's Diagnosed: videos
Clinical criteria for sepsis (qSOFA, SIRS), blood cultures, inflammatory markers (e.g., CRP, procalcitonin), and organ function tests (liver enzymes, creatinine, arterial blood gases).
Treatment:
Intravenous antibiotics, fluid resuscitation, vasopressors for low blood pressure, mechanical ventilation for respiratory failure, and immunomodulatory therapies in severe cases.us antibiotics, fluid resuscitation, vasopressors for low blood
Medications:
Broad-spectrum antibiotics (e.g., piperacillin-tazobactam, meropenem ), corticosteroids (e.g., hydrocortisone for refractory septic shock), and biologics targeting cytokines (e.g., tocilizumab for IL-6).
Prevalence:
How common the health condition is within a specific population.
Sepsis affects 49 million people annually worldwide, with cytokine storm occurring in a subset of severe cases.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Older age, chronic illnesses (e.g., diabetes, cancer), immunosuppression, major surgeries, and infections (e.g., pneumonia, urinary tract infections).
Prognosis:
The expected outcome or course of the condition over time.
High mortality rate (25–50%) in severe cases, particularly without prompt treatment; survivors may have long-term complications.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Septic shock, acute respiratory distress syndrome (ARDS), multiple organ failure, and long-term physical and cognitive impairments.
Rhabdomyolysis-related toxicity (myoglobin release)
Specialty: Toxicology
Category: Endogenous Toxins
Sub-category: Pathologic Toxins
Symptoms:
muscle pain; weakness; dark-colored urine; fatigue; swelling; nausea; confusion; irregular heart rhythms in severe cases; muscle pain; weakness; dark-colored urine; fatigue
Root Cause:
The breakdown of skeletal muscle releases myoglobin and other intracellular contents, leading to kidney damage and metabolic disturbances.
How it's Diagnosed: videos
Elevated creatine kinase (CK) levels, myoglobin in the urine, blood tests for electrolyte imbalances, and kidney function tests.
Treatment:
Aggressive intravenous fluid therapy to maintain urine output, correction of electrolyte imbalances, dialysis in severe kidney failure, and treating underlying causes.us fluid therapy to maintain urine output, correction of electrolyte imbalances, dialysis in severe kidney failure, and treating und
Medications:
No specific medications; supportive treatments include sodium bicarbonate or mannitol to alkalinize urine and prevent myoglobin toxicity. Electrolyte management may require potassium binders or calcium gluconate.
Prevalence:
How common the health condition is within a specific population.
Varies depending on the cause; commonly associated with trauma, extreme exercise, drug use, or infections. Incidence estimated at 26,000 cases annually in the U.S.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Traumatic injuries, prolonged immobility, heatstroke, excessive exercise, certain medications (e.g., statins, fibrates), or toxins.
Prognosis:
The expected outcome or course of the condition over time.
Favorable with early treatment, but severe cases can lead to acute kidney injury (AKI) or death if untreated.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Acute kidney failure, hyperkalemia, metabolic acidosis, compartment syndrome, and disseminated intravascular coagulation (DIC).